Find clinical trials for Pancreatic Cancer in London, England
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Pancreatic Cancer trials near London, England, GBR:
with either gemcitabine plus nab-paclitaxel (G/NP) or FOLFIRINOX in the treatment of participants with locally advanced, unresectable pancreatic...
Phase 3
London, United Kingdom and 89 other locations
or without SBP-101 in subjects previously untreated for metastatic pancreatic ductal adenocarcinoma (PDA), including subjects who have recei...
Phase 2, Phase 3
London, City Of London, United Kingdom and 91 other locations
is to assess the safety and efficacy of OncoSil™ when given in addition to standard FOLFIRINOX chemotherapy for treatment of Locally Advanced Pancreatic...
Phase 2
London, United Kingdom and 15 other locations
This trial will study tisotumab vedotin to find out whether it is an effective treatment for certain solid tumors and what side effects (unwanted eff...
Phase 2
London, Other, United Kingdom and 60 other locations
of AZD0901 as monotherapy and in combination with anti-cancer agents in participants with locally advanced unresectable or metastatic solid ...
Phase 2
London, United Kingdom and 46 other locations
This is a multi-centre, investigator-initiated, dose escalation, Phase I trial of the combination of the FAK inhibitor, Defactinib (VS-6063), and the...
Phase 1
London, United Kingdom and 4 other locations
This research is designed to determine if experimental treatment with PARP inhibitor, AZD5305, alone, or in combination with anti-cancer age...
Phase 1, Phase 2
Sutton, United Kingdom and 71 other locations
taken forward for further testing.Part 2: Based on the Part 1 results, another part in patients with liver metastases from CRC and pancreatic...
Phase 1
Sutton, United Kingdom and 3 other locations
This is a Phase I/II, open-label, multi-center, multi-national, dose escalation, single agent study to assess the safety, tolerability, PK, PD, immun...
Phase 2
London, United Kingdom and 64 other locations
efficacy of AZD9574 individually and in combination with anti-cancer agents in 490 participants with advanced cancer that has recur...
Phase 1, Phase 2
London, United Kingdom and 30 other locations
Clinical trials
Research sites
Resources
Legal